All other secondary outcome measures, although showing numerically favorable values in both of the interferon arms, did not reach statistical significance, both when compared between the two intervention groups and when compared with the control group.
← all excerpts
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.
1
—
—